Epitome Therapeutics is a biotechnology company advancing precision epigenome editing for programmable gene expression. Founded in 2025 as a spin-off from EMBL, Epitome is developing CADENCE, a next-generation platform designed to enable the precise and durable calibration of gene dosage without alt... Read more
Org chart
Collapse
No reports!
Teams
This company has no teams yet
Offices
This company has no offices yet
